On May 14, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…
On May 12, 2020, the National Research Council of Canada (NRC) and the University of Saskatchewan’s (USask) Vaccine…
On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…
On May 11, 2020, Regeneron and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado…
On May 11, 2020, Bellerophon Therapeutics announced the FDA accepted its Investigational New Drug (IND) application, allowing the…
On May 11, 2020, Airway Therapeutics announced a filing with the Respiratory Diseases Branch of the National Institutes…
On May 11, 2020, Arbutus Biopharma announced the establishment of a new research initiative focused on the identification…
On May 8, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had funded…
On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…
On May 8, 2020, the CoVIg-19 Plasma Alliance was announced, an unprecedented partnership of the world’s leading plasma…
On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…
On May 7, 2020, City of Hope announced that two existing drugs using advanced genomic technology, were being…
On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
On May 5, 2020, the U.S. Dept. of Veterans Affairs (VA) announced the Airborne Hazards and Open Burn…
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
On May 3, 2020, AbCellera announced it had received a commitment of up to $175.6 million in support…
On May 1, 2020, Gilead announced the FDA granted emergency use authorization (EUA) for the investigational antiviral remdesivir…
On May 1, 2020, a University of Southern California (USC) study suggested that temporarily suppressing the body’s immune…
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
On May 1, 2020, Janssen Pharma, a Johnson & Johnson company, announced the U.S. Food and Drug Administration…
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…